Hillary Millar Quinn

Hillary Millar Quinn currently serves as the Assistant Director of Scientific Development for Discovery Oncology at Labcorp since March 2025, focusing on guiding clients in drug candidate development and advancing R&D projects. Prior to this role, Hillary co-founded The Therapeutic Innovations Group, providing nonclinical consulting for various biopharma entities, and held positions at Century Therapeutics, where leadership in preclinical pharmacology was demonstrated from 2019 to 2024. Hillary's extensive experience includes significant contributions at The Janssen Pharmaceutical Companies, where strategic roles spanned from research scientist to senior scientist, overseeing projects in large-molecule oncology therapies and managing international teams. Earlier career highlights include work at Centocor, advancing oncology research through animal model establishment and complex in vivo studies. Academic qualifications include a Master of Science in Pharmacology from Jefferson Health and a Bachelor of Science in Small Animal Science from Delaware Valley University.